Analysts at StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research report issued on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
The firm has a 50-day moving average price of $0.85 and a 200 day moving average price of $0.74. Onconova Therapeutics has a 52 week low of $0.55 and a 52 week high of $1.45. The firm has a market capitalization of $20.90 million, a P/E ratio of -1.09 and a beta of 1.38.
Onconova Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Onconova Therapeutics
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- MarketBeat Week in Review – 4/29 – 5/3
- What Investors Need to Know to Beat the Market
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- The Significance of Brokerage Rankings in Stock Selection
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.